Back to Results
First PageMeta Content
Medicine / Chemistry / QT interval / Richmond Pharmacology Ltd / Piperazines / Syndromes / Moxifloxacin / Long QT syndrome / Levofloxacin / Cardiac electrophysiology / Physiology / Cardiac dysrhythmia


Microsoft PowerPoint - TQT STudies-VKliPha eV 2009_Final Version_CORRECTED_15012010
Add to Reading List

Document Date: 2010-01-15 06:32:36

Open Document

File Size: 97,71 KB

Share Result on Facebook

City

London / /

Company

Dole / Breidinger SA / Jorg Taubel Richmond Pharmacology Ltd. / Agency for the Evaluation / Richmond Pharmacology Limited / /

Country

United Kingdom / United States / Canada / /

Facility

St George's University of London / /

IndustryTerm

non-cardiovascular medicinal products / chemical entities / consistent effective quality systems / /

MedicalCondition

overactive bladder / Torsades de Pointes / /

Organization

European Agency for the Evaluation of Medicinal Products / FDA / Committee for Proprietary Medicinal Product / European Union / Therapeutic Products Directorate / Human Medicines Evaluation Unit / University of London / /

Person

Ulrike Lorch / Keith Berelowitz / Peter Smetana / Katerina Hnatkova / Marek Malik / Asif Naseem / Anna Schmidt / /

Position

Bedigian MP / subsequent cardiologist / /

Product

Levofloxacin / /

Technology

Drug Development / /

URL

http /

SocialTag